Literature DB >> 6546922

Glucagon-related peptides in the human gastrointestinal mucosa.

F G Baldissera, J J Holst.   

Abstract

We studied the chromatographic profile and the distribution of glucagon-related peptides in the human gastrointestinal mucosa, using radioimmunoassays directed against the glucagon 6-15 and 19-29 sequences, and against the glicentin sequences 15-30 and 61-69, and a radioreceptor assay for glucagon. Very small amounts of glucagon-related peptides were found in the gastric mucosa, whereas at least four different components could be identified in the distal intestine. One component (mean concentration 130 pmol/g ileal mucosa) is similar to porcine glicentin for size and C-terminal extension, but differs from the glucagon part of the molecule in the N-terminal extension. A second component (mean concentration 131 pmol/g) is probably identical to porcine peak II enteroglucagon (glicentin 33-69), and a third component (7.9 pmol/g) seems to be identical with glucagon. A fourth component containing the glucagon sequence plus an N-terminal extension was also identified (1.7 pmol/g). Thus the human intestinal mucosa contains large amounts of peptides containing the glucagon sequence; at least one of these probably also possesses glucagon-like bioactivity. The proposed structures of the four components are consistent with the base sequence of the first half of the human glucagon gene.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6546922     DOI: 10.1007/bf00252412

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  15 in total

1.  Chromatographic pattern of human intestinal glucagon-like immunoreactivity (GLI).

Authors:  I Valverde; M L Villaneuva; I Lozano; D Román; M Díaz-Fierros; J Marco
Journal:  J Clin Endocrinol Metab       Date:  1973-01       Impact factor: 5.958

2.  Large glucagon immunoreactivity in extracts of pancreas.

Authors:  D Rigopoulou; I Valverde; J Marco; G Faloona; R H Unger
Journal:  J Biol Chem       Date:  1970-02-10       Impact factor: 5.157

3.  The hormonal pattern of intestinal adaptation. A major role for enteroglucagon.

Authors:  S R Bloom; J M Polak
Journal:  Scand J Gastroenterol Suppl       Date:  1982

4.  Exon duplication and divergence in the human preproglucagon gene.

Authors:  G I Bell; R Sanchez-Pescador; P J Laybourn; R C Najarian
Journal:  Nature       Date:  1983 Jul 28-Aug 3       Impact factor: 49.962

5.  Relationship of glicentin to proglucagon and glucagon in the porcine pancreas.

Authors:  A J Moody; J J Holst; L Thim; S L Jensen
Journal:  Nature       Date:  1981-02-05       Impact factor: 49.962

6.  Isolation of glucagon-37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno-ileum. Isolation of the peptide.

Authors:  D Bataille; A M Coudray; M Carlqvist; G Rosselin; V Mutt
Journal:  FEBS Lett       Date:  1982-09-06       Impact factor: 4.124

7.  Isolation of glucagon-37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno-ileum. Characterization of the peptide.

Authors:  D Bataille; K Tatemoto; C Gespach; H Jörnvall; G Rosselin; V Mutt
Journal:  FEBS Lett       Date:  1982-09-06       Impact factor: 4.124

8.  Circulating glucagon after total pancreatectomy in man.

Authors:  J J Holst; J H Pedersen; F Baldissera; F Stadil
Journal:  Diabetologia       Date:  1983-11       Impact factor: 10.122

9.  Molecular heterogeneity of glucagon in normal subjects and in patients with glucagon-producing tumours.

Authors:  J J Holst
Journal:  Diabetologia       Date:  1983-05       Impact factor: 10.122

10.  Extraction, gel filtration pattern, and receptor binding of porcine gastrointestinal glucagon-like immunoreactivity.

Authors:  J J Holst
Journal:  Diabetologia       Date:  1977-04       Impact factor: 10.122

View more
  13 in total

1.  Steroid-induced insulin resistance and impaired glucose tolerance are both associated with a progressive decline of incretin effect in first-degree relatives of patients with type 2 diabetes.

Authors:  D H Jensen; K Aaboe; J E Henriksen; A Vølund; J J Holst; S Madsbad; T Krarup
Journal:  Diabetologia       Date:  2012-05       Impact factor: 10.122

2.  Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus.

Authors:  F K Knop; T Vilsbøll; S Madsbad; J J Holst; T Krarup
Journal:  Diabetologia       Date:  2007-01-16       Impact factor: 10.122

3.  The ontogeny and distribution of glucagon- and pancreatic polypeptide-immunoreactive cells in the gastrointestinal tract of the chicken.

Authors:  B C Alison
Journal:  Anat Embryol (Berl)       Date:  1990

4.  Reduction of insulinotropic properties of GLP-1 and GIP after glucocorticoid-induced insulin resistance.

Authors:  Marie Eriksen; David H Jensen; Siri Tribler; Jens J Holst; Sten Madsbad; Thure Krarup
Journal:  Diabetologia       Date:  2015-03-09       Impact factor: 10.122

5.  Oxyntomodulin from distal gut. Role in regulation of gastric and pancreatic functions.

Authors:  B Schjoldager; P E Mortensen; J Myhre; J Christiansen; J J Holst
Journal:  Dig Dis Sci       Date:  1989-09       Impact factor: 3.199

6.  Pancreatic and intestinal processing of proglucagon in man.

Authors:  C Orskov; J J Holst; S S Poulsen; P Kirkegaard
Journal:  Diabetologia       Date:  1987-11       Impact factor: 10.122

7.  Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomy.

Authors:  J Miholic; C Orskov; J J Holst; J Kotzerke; H J Meyer
Journal:  Dig Dis Sci       Date:  1991-10       Impact factor: 3.199

Review 8.  Intra-islet glucagon-like peptide 1.

Authors:  Genevieve E Fava; Emily W Dong; Hongju Wu
Journal:  J Diabetes Complications       Date:  2016-05-20       Impact factor: 2.852

9.  Resolution of type 2 diabetes following gastric bypass surgery: involvement of gut-derived glucagon and glucagonotropic signalling?

Authors:  F K Knop
Journal:  Diabetologia       Date:  2009-09-01       Impact factor: 10.122

Review 10.  What Is an L-Cell and How Do We Study the Secretory Mechanisms of the L-Cell?

Authors:  Rune E Kuhre; Carolyn F Deacon; Jens J Holst; Natalia Petersen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-08       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.